Andrew Blight - Net Worth and Insider Trading
Andrew Blight Net Worth
The estimated net worth of Andrew Blight is at least $9 dollars as of 2024-11-12. Andrew Blight is the Chief Scientific Officer of Acorda Therapeutics Inc and owns about 638 shares of Acorda Therapeutics Inc (ACORQ) stock worth over $9. Details can be seen in Andrew Blight's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Blight has not made any transactions after 2017-02-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Blight
Andrew Blight Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Blight owns 1 companies in total, including Acorda Therapeutics Inc (ACORQ) .
Click here to see the complete history of Andrew Blight’s form 4 insider trades.
Insider Ownership Summary of Andrew Blight
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACORQ | Acorda Therapeutics Inc | 2017-02-09 | Chief Scientific Officer |
Andrew Blight Latest Holdings Summary
Andrew Blight currently owns a total of 1 stock. Andrew Blight owns 638 shares of Acorda Therapeutics Inc (ACORQ) as of February 9, 2017, with a value of $9.
Latest Holdings of Andrew Blight
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACORQ | Acorda Therapeutics Inc | 2017-02-09 | 638 | 0.01 | 9 |
Holding Weightings of Andrew Blight
Andrew Blight Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Blight has made a total of 0 transactions in Acorda Therapeutics Inc (ACORQ) over the past 5 years. The most-recent trade in Acorda Therapeutics Inc is the sale of 563 shares on February 9, 2017, which brought Andrew Blight around $2 Million.
Insider Trading History of Andrew Blight
- 1
Andrew Blight Trading Performance
Andrew Blight Ownership Network
Ownership Network List of Andrew Blight
Ownership Network Relation of Andrew Blight
Andrew Blight Owned Company Details
What does Acorda Therapeutics Inc do?
Who are the key executives at Acorda Therapeutics Inc?
Andrew Blight is the Chief Scientific Officer of Acorda Therapeutics Inc. Other key executives at Acorda Therapeutics Inc include CEO and President Ron Cohen , Chief Financial Officer Michael A Gesser , and General Counsel Neil S. Belloff .
Acorda Therapeutics Inc (ACORQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acorda Therapeutics Inc (ACORQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acorda Therapeutics Inc (ACORQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acorda Therapeutics Inc (ACORQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acorda Therapeutics Inc Insider Transactions
Andrew Blight Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Blight. You might contact Andrew Blight via mailing address: C/o Acorda Therapeutics, Inc., 420 Saw Mill River Road, Ardsley Ny 10502.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
